Integrated Approach to Biomarkers


Biomarkers Inform the Drug Development Process for Large and Small Molecule Drugs

Altasciences can extract meaningful data from measuring various intracellular, membrane-bound, and secreted circulating biomarkers to inform the development process.

We will help guide you towards a robust and fit-for-purpose biomarker solution involving veteran scientists, toxicologists and clinical pharmacologists to develop a comprehensive preclinical to clinical plan to maximize the translation of results from one phase to the next. 

Expertise working with:
  • Cytokines
  • Chemokines
  • Multiplexed assays
  • Complement factor(s) quantitation
Experience with the following studies:
  • Oncology
  • Metabolic Disease
  • Neurology
  • Diabetes
  • Inflammation
  • And more

Let’s get started!

You may also be interested in the following:

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.